When the first biosimilar came on the market seven years after Humira's patent expired, prices really didn't go down. Call it an implied collusion of prices, but It takes typically until two or three biosimilars come to market to see the prices really drop. That's why we need to reduce the hurdles and get more biosimilars on the market. Right now, we're not doing well. (14:47–14:53)
CLAIM
Asserts that prices typically drop only after two or three biosimilars enter the market.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.